Equity Capital Markets

Company · CIK 1739614

Inhibrx, Inc.

CIK1739614 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inCA
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2020-11-13

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-259313
ShelfEffective
 2021-09-032021-09-031
333-240135
IPOFinal prospectus
 2020-07-282020-08-194
333-231907
First-time registrationWithdrawn
 2019-06-032019-11-083

Filings

10
FiledFilingRegistrationAccession
2021-09-03S-3ASRShelf registered 333-2593130001739614-21-000090
2020-08-19424B4Final prospectus 333-2401350001628280-20-012884
2020-08-18EFFECTDeclared effective 333-2401359999999995-20-002182
2020-08-12S-1/AAmendment 333-2401350001628280-20-012466
2020-07-28S-1Registration filed 333-2401350001628280-20-010679
2020-06-26DRSDraft made public 377-032520001628279-20-000120
2019-11-08RWWithdrawn 333-2319070001193125-19-288411
2019-08-20S-1/AAmendment 333-2319070001193125-19-225351
2019-06-03S-1Registration filed 333-2319070001193125-19-164114
2019-01-07DRSDraft made public 377-024540000950123-19-000038

All filings of this company · CSV